Tocilizumab Stabilizes Renal Function in Kidney Transplant Recipients with Chronic Active Antibody Mediated Rejection (CAAMR).

被引:0
|
作者
Patel, S. [1 ]
Mohan, S. [1 ]
Fernandez, H. [1 ]
Batal, I. [1 ]
Ratner, L. [1 ]
Crew, J. [1 ]
机构
[1] Columbia Univ, New York, NY USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
205
引用
收藏
页码:326 / 326
页数:1
相关论文
共 50 条
  • [1] Tocilizumab for treatment of chronic active antibody-mediated rejection in kidney transplant recipients
    Boonpheng, Boonphiphop
    De Castro, Iris Camille C.
    Ng, Yue-Harn
    Blosser, Christopher
    Bakthavatsalam, Ramasamy
    Gimferrer, Idoia
    Smith, Kelly
    Leca, Nicolae
    [J]. CLINICAL TRANSPLANTATION, 2023, 37 (05)
  • [2] Tocilizumab for the treatment of chronic antibody mediated rejection in kidney transplant recipients
    Khairallah, Pascale
    Robbins-Juarez, Shelief
    Patel, Shefali
    Shah, Vaqar
    Toma, Katherine
    Fernandez, Hilda
    Dube, Geoffrey K. K.
    King, Kristen
    Mohan, Sumit
    Husain, Syed Ali
    Morris, Heather
    Crew, Russell John
    [J]. CLINICAL TRANSPLANTATION, 2023, 37 (01)
  • [3] Use of Tocilizumab in the treatment of chronic active antibody-mediated rejection in pediatric kidney transplant recipients
    Sangermano, Maria
    Negrisolo, Susanna
    Antoniello, Benedetta
    Vadori, Marta
    Cozzi, Emanuele
    Benetti, Elisa
    [J]. HUMAN IMMUNOLOGY, 2024, 85 (05)
  • [4] USE OF TOCILIZUMAB IN THE TREATMENT OF CHRONIC ACTIVE ANTIBODY-MEDIATED REJECTION IN PEDIATRIC KIDNEY TRANSPLANT RECIPIENTS
    Sangermano, Maria
    Negrisolo, Susanna
    Antoniello, Benedetta
    Carraro, Andrea
    Vadori, Marta
    Cuciz, Elisa
    Longo, Germana
    Vidal, Enrico
    Meneghesso, Davide
    Parolin, Mattia
    Cozzi, Emanuele
    Benetti, Elisa
    [J]. PEDIATRIC NEPHROLOGY, 2023, 38 : S52 - S53
  • [5] Tocilizumab in Chronic Active Antibody-Mediated Rejection in Kidney Transplant Recipients: A Case Series.
    Boonpheng, B.
    Bakthavatsalam, R.
    Blosser, C. D.
    De Castro, I. C.
    Gimferrer, I.
    Ng, Y.
    Leca, N.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 959 - 959
  • [6] Efficacy and Safety of Tocilizumab in the Treatment of Acute Active Antibody-mediated Rejection in Kidney Transplant Recipients
    Pottebaum, April A.
    Venkatachalam, Karthikeyan
    Liu, Chang
    Brennan, Daniel C.
    Murad, Haris
    Malone, Andrew F.
    Alhamad, Tarek
    [J]. TRANSPLANTATION DIRECT, 2020, 6 (04): : E543
  • [7] ACUTE AND CHRONIC ACTIVE ANTIBODY MEDIATED REJECTION IN KIDNEY TRANSPLANT RECIPIENTS: PROGNOSIS AND TREATMENT
    Yilmaz, Vural Taner
    Kocak, Huseyin
    Suleymanlar, Gultekin
    Cetinkaya, Ramazan
    Akkaya, Bahar
    Akbas, Halide
    Koksoy, Sadi
    Kisaoglu, Abdullah
    Aydinli, Bulent
    [J]. TRANSPLANT INTERNATIONAL, 2017, 30 : 527 - 527
  • [8] Rationale for the IMAGINE study for chronic active antibody-mediated rejection (caAMR) in kidney transplantation
    Nickerson, Peter W. W.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 38 - 44
  • [9] TOCILIZUMAB TREATMENT IN DSA POSITIVE ANTIBODY MEDIATED REJECTION AMONG KIDNEY TRANSPLANT RECIPIENTS
    Cseprekal, Orsolya
    Marton, Adrienn
    Molnar, Sara
    Patonai, Attila
    Attila, Fintha
    Micsik, Tamas
    Szilard, Torok
    Wagner, Laszlo
    Kobori, Laszlo
    Remport, Adam
    [J]. TRANSPLANT INTERNATIONAL, 2021, 34 : 292 - 292
  • [10] TOCILIZUMAB TREATMENT IN DSA POSITIVE ANTIBODY MEDIATED REJECTION AMONG KIDNEY TRANSPLANT RECIPIENTS
    Cseprekal, Orsolya
    Marton, Adrienn
    Molnar, Sara
    Patonai, Attila
    Fintha, Attila
    Micsik, Tamas
    Torok, Szilard
    Mathe, Zsolt
    Wagner, Laszlo
    Kobori, Laszlo
    Remport, Adam
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 2074 - 2074